SCHEMBL658436

SCHEMBL658436

CC1(C)OC(=O)C(=Cc2ccc(Cl)cc2)C(=O)O1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.65
CRHBP P24387 3/20 0.65
CRHR2 Q13324 3/20 0.65
KMT2A Q03164 8/20 0.55
SIRT1 Q96EB6 2/20 0.53
HPGD P15428 4/20 0.50
MEN1 O00255 6/20 0.46
KDM4E B2RXH2 2/20 0.46
PKM P14618 2/20 0.46
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2C19 P33261 2/20 0.44
POLB P06746 1/20 0.44
NPSR1 Q6W5P4 2/20 0.43
MAPT P10636 2/20 0.43
LMNA P02545 2/20 0.43
GSK3B P49841 1/20 0.43
PIM1 P11309 1/20 0.43
PIM2 Q9P1W9 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17199432 0.83 ALDH1A1 (0.67) ALDH1A1CRHBPCRHR2KMT2ASIRT1
SCHEMBL1587773 0.82 ALDH1A1 (0.66) ALDH1A1CRHBPCRHR2KMT2ASIRT1
SCHEMBL31462528 0.82 KMT2A (0.56) ALDH1A1CRHBPCRHR2KMT2ASIRT1
SCHEMBL435198 0.81 SIRT1 (0.71) ALDH1A1CRHBPCRHR2KMT2ASIRT1
SCHEMBL12345520 0.81 ALDH1A1 (0.65) ALDH1A1CRHBPCRHR2KMT2ASIRT1
SCHEMBL2074007 0.81 ALDH1A1 (0.65) ALDH1A1CRHBPCRHR2KMT2ASIRT1
SCHEMBL22409612 0.80 APP (0.61) ALDH1A1CRHBPCRHR2KMT2AMEN1
SCHEMBL22409614 0.80 APP (0.61) ALDH1A1CRHBPCRHR2KMT2AMEN1
SCHEMBL3076077 0.79 KMT2A (0.65) ALDH1A1CRHBPCRHR2KMT2AMAPT
SCHEMBL9196949 0.79 ALDH1A1 (1.00) ALDH1A1CRHBPCRHR2KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11161823-B2 Anticancer 1,3-dioxane-4,6-dione derivatives and method of combinatorial synthesis thereof NATIONAL GUARD HEALTH AFFAIRS (SA) 2021-11-02 US disclosed
US-20200290975-A1 ANTICANCER 1,3-DIOXANE-4,6-DIONE DERIVATIVES AND METHOD OF COMBINATORIAL SYNTHESIS THEREOF NATIONAL GUARD HEALTH AFFAIRS (SA) 2020-09-17 US disclosed
EP-2349999-B1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIV SAARLAND (DE) 2016-01-27 EP disclosed
US-8912186-B2 Allosteric protein kinase modulators UNIVERSITAET DES SAARLANDES (DE) 2014-12-16 US disclosed
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2012-02-23 US disclosed
EP-2349999-A1 ALLOSTERIC PROTEIN KINASE MODULATORS Universität des Saarlandes (DE) 2011-08-03 EP disclosed
WO-2010043711-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2010-04-22 WO disclosed
EP-2177510-A1 Allosteric protein kinase modulators Universität des Saarlandes (DE) 2010-04-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11161823-B2 Anticancer 1,3-dioxane-4,6-dione derivatives and method of combinatorial synthesis thereof PDK1, PDHA1, PDHA2 ALDH1A1 7/4885CRHBP 3904/4885CRHR2 3663/4885
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS AURKC, AURKA, AURKB ALDH1A1 4784/4885CRHBP 2901/4885CRHR2 4615/4885
US-20200290975-A1 ANTICANCER 1,3-DIOXANE-4,6-DIONE DERIVATIVES AND METHOD OF COMBINATORIAL SYNTHESIS THEREOF PDK1, PDHA1, PDHA2 ALDH1A1 7/4885CRHBP 3904/4885CRHR2 3663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.